TriSalus Life Sciences, Inc.
NASDAQ:TLSI · NASDAQ Global Market
+$0.02 today
Vol 1.00M · Avg 0.38M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-22.87%
Period High
$7.50
Period Low
$2.52
Latest
$4.08
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Anteris Technologies Global Corp.
NASDAQ:AVR
$347.10M
Prenetics Global Limited
NASDAQ:PRE
$342.98M
Armata Pharmaceuticals, Inc.
AMEX:ARMP
$254.77M
Perspective Therapeutics, Inc.
AMEX:CATX
$232.14M
Profound Medical Corp.
NASDAQ:PROF
$205.61M
MaxCyte, Inc.
NASDAQ:MXCT
$126.94M
Nano-X Imaging Ltd.
NASDAQ:NNOX
$119.35M
Owlet, Inc.
NYSE:OWLT
$91.20M
Neuronetics, Inc.
NASDAQ:STIM
$84.40M
LENSAR, Inc.
NASDAQ:LNSR
$71.29M
What is the latest TLSI filing?
The latest filing shown is SC 13G/A dated May 20, 2026.
How many recent filings does TLSI have?
Intrinsic Alpha currently shows 20 recent filings for TLSI.
Explore More
Continue the stock analysis
Jump to another research area for this company.